Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
REGENXBIO Inc. (RGNX) had Receiveable Turnover of 3.64 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$90.24M |
|
$-263.49M |
|
$37.21M |
|
$53.03M |
|
$358.37M |
|
$-268.13M |
|
$4.48M |
|
$-263.65M |
|
$-263.65M |
|
$-263.49M |
|
$-263.49M |
|
$-263.49M |
|
$-263.49M |
|
$-268.13M |
|
$-250.12M |
|
43.73M |
|
43.73M |
|
$-6.02 |
|
$-6.02 |
|
| Balance Sheet Financials | |
$334.97M |
|
$132.10M |
|
$239.00M |
|
$573.97M |
|
$130.27M |
|
-- |
|
$131.96M |
|
$262.23M |
|
$311.74M |
|
$311.74M |
|
$311.74M |
|
44.05M |
|
| Cash Flow Statement Financials | |
$-218.41M |
|
$190.94M |
|
$-34.97M |
|
$98.98M |
|
$36.55M |
|
$-62.43M |
|
$40.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.76% |
|
-297.12% |
|
-297.12% |
|
-277.17% |
|
-292.15% |
|
-291.99% |
|
$-228.37M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
|
Receiveable Turnover |
3.64 |
100.27 |
|
-84.52% |
|
-84.52% |
|
-45.91% |
|
-84.52% |
|
$7.08 |
|
$-5.22 |
|
$-4.99 |
|